Differential in vivo effects of neurturin and glial cell-line-derived neurotrophic factor

Michael R. Hoane, Amit G. Gulwadi, Sharon Morrison, Ginny Hovanesian, Mark D. Lindner, Weng Tao

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Glial cell-line derived neurotrophic factor (GDNF) and neurturin (NTN) are structurally homologous, and they seem to produce similar effects in vitro. Tissue distributions of their respective receptors, GFRα-1 and GFRα- 2, reveal overlapping but distinct patterns of expression, which implies that the in vivo actions of GDNF and NTN may be different. In the present study, a direct comparison of the in vivo effects of GDNF and NTN was performed using osmotic minipumps delivering either GDNF or NTN over a 30-day period into rat lateral cerebral ventricles. Amphetamine-induced activity levels were increased in both NTN- and GDNF-treated animals, with higher activity levels achieved by GDNF than NTN. The increase in amphetamine-induced activity levels persisted for 2 weeks and returned to control levels at the end of the third week. NTN-treated rats showed higher dopamine levels in the mediodorsal striatum, relative to the ventrolateral striatum. In contrast, no significant change in the regional distribution of dopamine levels was observed in GDNF treated or control animals. On the other hand, an increase in ventrolateral and mediodorsal striatal dopamine utilization was apparent in GDNF-treated animals, while NTN-treated animals showed increased levels of dopamine utilization only in the ventrolateral striatum. With respect to potential adverse effects, GDNF administration resulted in weight loss and the emergence of allodynia. No weight loss or allodynia was detectable with chronic NTN administration. These results suggest that although GDNF and NTN share structural and functional similarities, they may have differential effects in vivo.

Original languageEnglish (US)
Pages (from-to)235-243
Number of pages9
JournalExperimental Neurology
Volume160
Issue number1
DOIs
StatePublished - Jan 1 1999
Externally publishedYes

Fingerprint

Neurturin
Glial Cell Line-Derived Neurotrophic Factor
Dopamine
Hyperalgesia
Amphetamine
Weight Loss
Corpus Striatum
Cerebral Ventricles
Lateral Ventricles
Tissue Distribution

Keywords

  • Dopaminergic
  • GDNF
  • Neurturin
  • Receptor
  • Signal transduction

ASJC Scopus subject areas

  • Neurology
  • Developmental Neuroscience

Cite this

Differential in vivo effects of neurturin and glial cell-line-derived neurotrophic factor. / Hoane, Michael R.; Gulwadi, Amit G.; Morrison, Sharon; Hovanesian, Ginny; Lindner, Mark D.; Tao, Weng.

In: Experimental Neurology, Vol. 160, No. 1, 01.01.1999, p. 235-243.

Research output: Contribution to journalArticle

Hoane, MR, Gulwadi, AG, Morrison, S, Hovanesian, G, Lindner, MD & Tao, W 1999, 'Differential in vivo effects of neurturin and glial cell-line-derived neurotrophic factor', Experimental Neurology, vol. 160, no. 1, pp. 235-243. https://doi.org/10.1006/exnr.1999.7175
Hoane, Michael R. ; Gulwadi, Amit G. ; Morrison, Sharon ; Hovanesian, Ginny ; Lindner, Mark D. ; Tao, Weng. / Differential in vivo effects of neurturin and glial cell-line-derived neurotrophic factor. In: Experimental Neurology. 1999 ; Vol. 160, No. 1. pp. 235-243.
@article{d05c42602e0e4c33be3f05b7bff13353,
title = "Differential in vivo effects of neurturin and glial cell-line-derived neurotrophic factor",
abstract = "Glial cell-line derived neurotrophic factor (GDNF) and neurturin (NTN) are structurally homologous, and they seem to produce similar effects in vitro. Tissue distributions of their respective receptors, GFRα-1 and GFRα- 2, reveal overlapping but distinct patterns of expression, which implies that the in vivo actions of GDNF and NTN may be different. In the present study, a direct comparison of the in vivo effects of GDNF and NTN was performed using osmotic minipumps delivering either GDNF or NTN over a 30-day period into rat lateral cerebral ventricles. Amphetamine-induced activity levels were increased in both NTN- and GDNF-treated animals, with higher activity levels achieved by GDNF than NTN. The increase in amphetamine-induced activity levels persisted for 2 weeks and returned to control levels at the end of the third week. NTN-treated rats showed higher dopamine levels in the mediodorsal striatum, relative to the ventrolateral striatum. In contrast, no significant change in the regional distribution of dopamine levels was observed in GDNF treated or control animals. On the other hand, an increase in ventrolateral and mediodorsal striatal dopamine utilization was apparent in GDNF-treated animals, while NTN-treated animals showed increased levels of dopamine utilization only in the ventrolateral striatum. With respect to potential adverse effects, GDNF administration resulted in weight loss and the emergence of allodynia. No weight loss or allodynia was detectable with chronic NTN administration. These results suggest that although GDNF and NTN share structural and functional similarities, they may have differential effects in vivo.",
keywords = "Dopaminergic, GDNF, Neurturin, Receptor, Signal transduction",
author = "Hoane, {Michael R.} and Gulwadi, {Amit G.} and Sharon Morrison and Ginny Hovanesian and Lindner, {Mark D.} and Weng Tao",
year = "1999",
month = "1",
day = "1",
doi = "10.1006/exnr.1999.7175",
language = "English (US)",
volume = "160",
pages = "235--243",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Differential in vivo effects of neurturin and glial cell-line-derived neurotrophic factor

AU - Hoane, Michael R.

AU - Gulwadi, Amit G.

AU - Morrison, Sharon

AU - Hovanesian, Ginny

AU - Lindner, Mark D.

AU - Tao, Weng

PY - 1999/1/1

Y1 - 1999/1/1

N2 - Glial cell-line derived neurotrophic factor (GDNF) and neurturin (NTN) are structurally homologous, and they seem to produce similar effects in vitro. Tissue distributions of their respective receptors, GFRα-1 and GFRα- 2, reveal overlapping but distinct patterns of expression, which implies that the in vivo actions of GDNF and NTN may be different. In the present study, a direct comparison of the in vivo effects of GDNF and NTN was performed using osmotic minipumps delivering either GDNF or NTN over a 30-day period into rat lateral cerebral ventricles. Amphetamine-induced activity levels were increased in both NTN- and GDNF-treated animals, with higher activity levels achieved by GDNF than NTN. The increase in amphetamine-induced activity levels persisted for 2 weeks and returned to control levels at the end of the third week. NTN-treated rats showed higher dopamine levels in the mediodorsal striatum, relative to the ventrolateral striatum. In contrast, no significant change in the regional distribution of dopamine levels was observed in GDNF treated or control animals. On the other hand, an increase in ventrolateral and mediodorsal striatal dopamine utilization was apparent in GDNF-treated animals, while NTN-treated animals showed increased levels of dopamine utilization only in the ventrolateral striatum. With respect to potential adverse effects, GDNF administration resulted in weight loss and the emergence of allodynia. No weight loss or allodynia was detectable with chronic NTN administration. These results suggest that although GDNF and NTN share structural and functional similarities, they may have differential effects in vivo.

AB - Glial cell-line derived neurotrophic factor (GDNF) and neurturin (NTN) are structurally homologous, and they seem to produce similar effects in vitro. Tissue distributions of their respective receptors, GFRα-1 and GFRα- 2, reveal overlapping but distinct patterns of expression, which implies that the in vivo actions of GDNF and NTN may be different. In the present study, a direct comparison of the in vivo effects of GDNF and NTN was performed using osmotic minipumps delivering either GDNF or NTN over a 30-day period into rat lateral cerebral ventricles. Amphetamine-induced activity levels were increased in both NTN- and GDNF-treated animals, with higher activity levels achieved by GDNF than NTN. The increase in amphetamine-induced activity levels persisted for 2 weeks and returned to control levels at the end of the third week. NTN-treated rats showed higher dopamine levels in the mediodorsal striatum, relative to the ventrolateral striatum. In contrast, no significant change in the regional distribution of dopamine levels was observed in GDNF treated or control animals. On the other hand, an increase in ventrolateral and mediodorsal striatal dopamine utilization was apparent in GDNF-treated animals, while NTN-treated animals showed increased levels of dopamine utilization only in the ventrolateral striatum. With respect to potential adverse effects, GDNF administration resulted in weight loss and the emergence of allodynia. No weight loss or allodynia was detectable with chronic NTN administration. These results suggest that although GDNF and NTN share structural and functional similarities, they may have differential effects in vivo.

KW - Dopaminergic

KW - GDNF

KW - Neurturin

KW - Receptor

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=0032751734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032751734&partnerID=8YFLogxK

U2 - 10.1006/exnr.1999.7175

DO - 10.1006/exnr.1999.7175

M3 - Article

VL - 160

SP - 235

EP - 243

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 1

ER -